KLRK1 and neoplasm: In NK cells, tumor-derived and recombinant TGF-β1 has been shown to downregulate the expression of NKp30 and NKG2D activating receptors involved in tumor recognition and DC editing (16, 17) and to modulate the chemokine receptor repertoire.